For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Calcineurin Inhibitor (CNI) Based Regimen | Baseline CNI therapy was continued after randomization and doses could be adjusted throughout the study as indicated, but therapy could not be withdrawn. Cyclosporine could be switched to tacrolimus, and vice versa. If warranted subjects could be switched between MMF, MPS, or AZA or their doses could be decreased, temporarily withheld, or discontinued. Subjects undergoing discontinuation of MMF, MPS, or AZA had to receive CS ≥2.5 mg/day of prednisone or the equivalent thereof. If subjects were not receiving MMF, MPS, or AZA at the time of randomization, the addition of MMF, MPS, or AZA was permitted if clinically indicated. If subjects were receiving CS at the time of randomization, CS was maintained at ≥2.5 mg/day of prednisone or the equivalent thereof. CS withdrawal was prohibited. If subjects were not receiving CS at the time of randomization, treatment could be initiated during the conduct of the study if clinically indicated. | None | None | 21 | 47 | 40 | 47 | View |
| Sirolimus (SRL) Based Regimen | All subjects discontinued Calcineurin inhibitors (CNI) after the morning dose on day 1. SRL was initiated with a loading dose of 6-12mg on day 1, followed by 2-4mg daily and was adjusted to maintain a whole blood trough concentration of 5-15ng/mL (high performance liquid chromatography \[HPLC\]). Once the SRL trough concentration was ≥ 5ng/mL, subjects receiving mycophenolate mofetil (MMF), mycophenolate sodium (MPS), or azathioprine (AZA) at randomization had doses reduced to ≤1.5 g/day, ≤1080 mg/day or ≤75 mg/day respectively. If warranted subjects could be switched between MMF, MPS, or AZA or their doses decreased, temporarily withheld, or discontinued. Subjects receiving corticosteroids (CS) at time of randomization or if MMF, MPS, or AZA was discontinued, had to receive CS ≥2.5mg/day of prednisone. Subjects not receiving MMF, MPS, or AZA at time of randomization remained on a minimum of double therapy (SRL and CS). Addition of MMF, MPS, or AZA was permitted. | None | None | 15 | 39 | 38 | 39 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Allergic reaction | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cellulitis | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Sepsis | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Aneurysm | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Arterial anomaly | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Deep vein thrombosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypertension | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Myocardial infarct | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Colitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Rectal hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Creatinine increased | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Gout | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperkalemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Confusion | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Encephalopathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Subdural hematoma | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Bronchitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pharyngitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory failure | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Sinusitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Angioedema | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Skin carcinoma | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Skin melanoma | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Acute kidney failure | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hematuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Kidney failure | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Prostatic carcinoma | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pyelonephritis | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urinary tract infection | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Neoplasm | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Transplant rejection | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Angina pectoris | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Atrial fibrillation | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Heart failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Left heart failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Thrombosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea and vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Lymphoma | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal Pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Accidental Injury | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Adenoma | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Allergic reaction | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Asthenia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Back pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Chest pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cyst | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Drug level decreased | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Drug level increased | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Face edema | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fever | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Flu syndrome | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hernia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hormone level altered | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Infection | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Lab test abnormal | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Malaise | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Neck pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Neoplasm | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pelvic pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Tolerance decreased | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Transplant rejection | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Aneurysm | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Angina pectoris | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Arrhythmia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Arterial anomaly | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Bradycardia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Cardiomegaly | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Cardiovascular physical finding | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Cyanosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Deep vein thrombosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Heart failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypertension | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypotension | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Left heart failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Myocardial infarct | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Peripheral vascular disorder | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Retinal artery occlusion | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Tachycardia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Thrombophlebitis superficial | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Thrombosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Anorexia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Cholecystitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Colitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Duodenal ulcer | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dyspepsia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Fecal incontinence | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastritis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastroesophageal reflux disease | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastrointestinal disorder | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Liver fatty deposit | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Liver function tests abnormal | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mouth ulceration | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Rectal disorder | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Rectal hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Stomatitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Tongue discoloration | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Thyroid disorder | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Antinuclear antibody present | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Ecchymosis | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Leukocytosis | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Leukopenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Lymphocytosis | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Neutropenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Thrombocytopenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Avitaminosis | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Creatinine increased | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Edema | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Glucose tolerance decreased | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Gout | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypercholesteremia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperglycemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperkalemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperlipemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypoglycemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypokalemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypophosphatemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Lactic dehydrogenase increased | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Peripheral edema | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Sgpt increased | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Thirst | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Weight loss | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Arthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Arthrosis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Bone disorder | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Joint disorder | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Myalgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Myopathy | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Osteopenia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Plantar fasciitis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Synovitis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Depression | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dizziness postural | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Emotional lability | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Hypesthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Insomnia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Nervousness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Neuropathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Paresthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Sleep disorder | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Somnolence | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Subdural hematoma | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Atelectasis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Bronchitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Cough increased | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Epistaxis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Hypoxia | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Laryngitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Lung infiltration nos | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pharyngitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory distress syndrome | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rhinitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Wheezing | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Acne | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Angioedema | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Dry skin | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Eczema | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Folliculitis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Fungal dermatitis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Herpes simplex | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Herpes zoster | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Maculopapular rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pruritic rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pruritus | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pustular rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Skin carcinoma | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Skin disorder | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Skin hypertrophy | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Subcutaneous emphysema | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Urticaria | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Abnormal vision | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Cataract specified | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Conjunctivitis | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Dry eyes | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Ear disorder | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Ear pain | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Eye disorder | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Eye hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Otitis media | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Retinal disorder | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Retinal edema | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Taste perversion | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Acute kidney failure | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Albuminuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Breast disorder | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Breast pain | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Hematuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hydronephrosis | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hydroureter | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Kidney function abnormal | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Prostatic specific antigen increase | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Testis disorder | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urinary incontinence | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urogenital disorder | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Allergic reaction other than drug | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Device malfunction | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Local reaction to procedure | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hypomagnesemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Seborrheic keratosis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Urinary retention | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |